Juliette Vergnaud - Concepedia

Author

Juliette Vergnaud

Also Known As

J. Vergnaud, J. Vergnaud-Gauduchon, Juliette Vergnaud, Juliette Vergnaud-Gauduchon, Vergnaud, Juliette, Vergnaud-Gauduchon, Juliette

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Institut Galien Paris-Saclay Centre National de la Recherche Scientifique Université Paris-Saclay Université Paris-Sud Inserm

About

Juliette Vergnaud is an author at Institut Galien Paris-Saclay specializing in medicine, nanomedicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	783
2	Engineering	7	7	549
3	Biomedical Engineering	6	6	467
4	Biochemistry	4	4	101
5	Natural Sciences	2	2	56

Juliette Vergnaud

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells Walhan Alshaer, Hervé Hillaireau, Juliette Vergnaud, Bioconjugate Chemistry Blank LiposomesSelective TargetingExtracellular MicrovesiclesImmunotherapyCancer Biology	2014	183
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages Nadège Grabowski, Hervé Hillaireau, Juliette Vergnaud, International Journal of Pharmaceutics NanoparticlesEngineeringNanomaterialsPolymeric NanoparticlesPharmaceutical Nanotechnology	2014	136
Aptamer-guided siRNA-loaded nanomedicines for systemic gene silencing in CD-44 expressing murine triple-negative breast cancer model Walhan Alshaer, Hervé Hillaireau, Juliette Vergnaud, Journal of Controlled Release NanomedicineNanotherapeuticsSystemic GeneEngineeringPolymer-drug Conjugate	2017	128
Altered functions of natural killer cells in response to L-Arginine availability Bruno Lamas, Juliette Vergnaud, Nicolas Gonçalves-Mendes, Cellular Immunology Host ResponseNatural Killer CellsAutoimmune DiseaseL-arginine AvailabilityInnate Immune System	2012	124
Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells Nadège Grabowski, Hervé Hillaireau, Juliette Vergnaud, International Journal of Pharmaceutics NanoparticlesEngineeringNanomaterialsNanotoxicologyNano-drug Delivery	2013	115
Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor Sabrina Valetti, Federica Maione, Simona Mura, Journal of Controlled Release NanoparticlesNanomedicineEngineeringPeptide-functionalized NanoparticlesPancreatic Cancer	2014	59
Lemon Verbena Infusion Consumption Attenuates Oxidative Stress in Dextran Sulfate Sodium-Induced Colitis in the Rat Adrien Rossary, Juliette Joubert‐Zakeyh, Juliette Vergnaud, Digestive Diseases and Sciences InflammationAnti-inflammatoryMucosal ImmunologyMedicinePhysiology	2011	52
Orange juice and its major polyphenol hesperidin consumption do not induce immunomodulation in healthy well-nourished humans Olivier Perche, Juliette Vergnaud, Christine Morand, Clinical Nutrition Food ChemistryNutritionFood Bioactive CompoundImmunologyPublic Health Nutrition	2013	49
Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model Thaís Leite Nascimento, Hervé Hillaireau, Juliette Vergnaud, International Journal of Pharmaceutics Cell-based Drug DeliveryNanomedicineHyaluronic Acid-conjugated LipoplexesPolymer-drug ConjugateTargeted Delivery	2016	48
Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial Jérémie Talvas, Ghislain Garrait, Nicolas Gonçalves-Mendes, Clinical Nutrition InflammationEsophageal Cancer PatientsEsophageal CancerImmunotoxicologyCancer Immunosurveillance	2014	47

Page 1